Sign in
4

Changes in Ownership

Chemomab Therapeutics Ltd. Filed Acc 0001178913-22-002093

Director bought 2,000 shares at $3.19 ($6,380)

From the SEC's structured data for this filing

Trades in this filing

Cohen Neil Harris · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-05-18 Purchase : show line 1 in the form +2,000 $3.19 $6,380 12,409 D
Open-market purchases · 2,000 sh · avg $3.19 · $6,380

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2022-03-07 Grant or award : show line 2 in the form Option to Purchase American Depositary Shares +6,820 6,820 D
2021-04-19 Grant or award : show line 3 in the form Option to Purchase American Depositary Shares +11,884 11,884 D
2021-03-16 Grant or award : show line 4 in the form Option to Purchase American Depositary Shares +688 688 D
Loading xslF345X03/zk2227874.xml…